ACET
Price
$0.67
Change
+$0.04 (+6.35%)
Updated
May 2 closing price
Capitalization
55.4M
16 days until earnings call
VIVS
Price
$2.00
Change
+$0.03 (+1.52%)
Updated
May 2 closing price
Capitalization
3.6M
18 days until earnings call
Ad is loading...

ACET vs VIVS

Header iconACET vs VIVS Comparison
Open Charts ACET vs VIVSBanner chart's image
Adicet Bio
Price$0.67
Change+$0.04 (+6.35%)
Volume$196.11K
Capitalization55.4M
VivoSim Lab
Price$2.00
Change+$0.03 (+1.52%)
Volume$171.94K
Capitalization3.6M
ACET vs VIVS Comparison Chart
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. VIVS commentary
May 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a StrongBuy and VIVS is a Hold.

Ad is loading...
COMPARISON
Comparison
May 04, 2025
Stock price -- (ACET: $0.67 vs. VIVS: $2.00)
Brand notoriety: ACET and VIVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACET: 45% vs. VIVS: 9%
Market capitalization -- ACET: $55.4M vs. VIVS: $3.6M
ACET [@Biotechnology] is valued at $55.4M. VIVS’s [@Biotechnology] market capitalization is $3.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileVIVS’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • VIVS’s FA Score: 0 green, 5 red.
According to our system of comparison, ACET is a better buy in the long-term than VIVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 4 TA indicator(s) are bullish while VIVS’s TA Score has 3 bullish TA indicator(s).

  • ACET’s TA Score: 4 bullish, 4 bearish.
  • VIVS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ACET is a better buy in the short-term than VIVS.

Price Growth

ACET (@Biotechnology) experienced а +14.37% price change this week, while VIVS (@Biotechnology) price change was +7.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

ACET is expected to report earnings on Aug 06, 2025.

VIVS is expected to report earnings on May 22, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACET($55.4M) has a higher market cap than VIVS($3.6M). VIVS YTD gains are higher at: 334.877 vs. ACET (-30.353).
ACETVIVSACET / VIVS
Capitalization55.4M3.6M1,539%
EBITDA-110.65MN/A-
Gain YTD-30.353334.877-9%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash176MN/A-
Total Debt17.2MN/A-
FUNDAMENTALS RATINGS
ACET vs VIVS: Fundamental Ratings
ACET
VIVS
OUTLOOK RATING
1..100
94
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
68
Overvalued
PROFIT vs RISK RATING
1..100
10089
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
8934
P/E GROWTH RATING
1..100
16100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (35) in the Medical Distributors industry is somewhat better than the same rating for VIVS (68) in the Biotechnology industry. This means that ACET’s stock grew somewhat faster than VIVS’s over the last 12 months.

VIVS's Profit vs Risk Rating (89) in the Biotechnology industry is in the same range as ACET (100) in the Medical Distributors industry. This means that VIVS’s stock grew similarly to ACET’s over the last 12 months.

ACET's SMR Rating (94) in the Medical Distributors industry is in the same range as VIVS (98) in the Biotechnology industry. This means that ACET’s stock grew similarly to VIVS’s over the last 12 months.

VIVS's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for ACET (89) in the Medical Distributors industry. This means that VIVS’s stock grew somewhat faster than ACET’s over the last 12 months.

ACET's P/E Growth Rating (16) in the Medical Distributors industry is significantly better than the same rating for VIVS (100) in the Biotechnology industry. This means that ACET’s stock grew significantly faster than VIVS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETVIVS
RSI
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 6 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 18 days ago
88%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WWD193.923.43
+1.80%
Woodward
INTR6.560.07
+1.08%
Inter & Co
SNPX2.42-0.04
-1.63%
Synaptogenix
IFRX1.73-0.12
-6.49%
InflaRx NV
SES0.81-0.08
-9.49%
SES AI Corp

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with OGI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
+6.60%
OGI - ACET
41%
Loosely correlated
+0.88%
ARWR - ACET
40%
Loosely correlated
+2.71%
DVAX - ACET
39%
Loosely correlated
-1.31%
RGNX - ACET
38%
Loosely correlated
+5.80%
RCKT - ACET
37%
Loosely correlated
+1.91%
More

VIVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIVS has been loosely correlated with GLTO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if VIVS jumps, then GLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIVS
1D Price
Change %
VIVS100%
+1.52%
GLTO - VIVS
38%
Loosely correlated
-0.33%
ORMP - VIVS
37%
Loosely correlated
+2.20%
ACET - VIVS
27%
Poorly correlated
+6.60%
KRRO - VIVS
26%
Poorly correlated
+13.81%
SLNO - VIVS
26%
Poorly correlated
+0.28%
More